Replicel Life Sciences Inc V.RP

Alternate Symbol(s): REPCF

Healthcare Biotechnology

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.

TSXV:RP - Post by User

Replicel Life Sciences Inc > RP trading

<< Previous

Bullboard Posts

Next >>

Comment by Ingiboyon Dec 08, 2023 11:29am

113 Views

Post# 35774953

RE:RE:RE:RP trading

O.K. now I am confused. What was that yesterday ? 384,000 shares traded 43 trades. End of day ask $.25, then we get this. All of those buyers yesterday and today nothing (so far).
I think I was hoping but not necessarily expecting some type of N/R. This stock is truly an enigma.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season